1. Stocks
  2. Rigel Pharmaceuticals
  3. Swot
swot-logo

Rigel Pharmaceuticals SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Rigel Pharmaceuticals has 22 Strengths, 2 Weaknesses, 1 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

Consistent Highest Return Stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over the Quarter (3 Months)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Month

Companies with Net Profit TTM 5X that of Net Profit in Previous Year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Annual Net Profits improving for last 2 years

Top Gainers

Stock with Low PE (PE < = 10)

Negative to Positive growth in Sales and Profit with Strong Price momentum

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

PE higher than Industry PE

Companies with High Debt

MFs increased their shareholding last quarter

Mutual Funds Decreased Shareholding in Past Month

Institutions decreased their shareholding last quarter

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks